Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Catchpole

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Medical Informatics = Medecine Et Informatique|April 1, 1988
Information systems for the community health servicesD E Avison, C P Catchpole
Nursing Times|August 1, 1987
Computers in nursing news. The tale of two systemsP Catchpole, D Avison, S Peart
Health Services Management|September 6, 1990
Making sense of Chinese walls or how to sort the purchasers from the providersP Catchpole, S Phoenix, D Ellis, et al.
Royal Society of Health Journal|February 1, 1982
The Quebec Medicare ProgrammeM Shipley, M Agass, A Bell, et al.
The Journal of General Virology|February 27, 2003
Alternative base pairs attenuate influenza A virus when introduced into the duplex region of the conserved viral RNA promoter of either the NS or the PA geneA P Catchpole, L J Mingay, E Fodor, et al.
BMC Research Notes|August 31, 2018
The manufacturing of human viral challenge agents for use in clinical studies to accelerate the drug development processAndrew P Catchpole, Daniel J Fullen, Nicolas Noulin, et al.
Eclinicalmedicine|October 4, 2024
Changes in memory and cognition during the SARS-CoV-2 human challenge studyWilliam Trender, Peter J Hellyer, Ben Killingley, et al.
Pulmonary Therapy|April 2, 2025
A Phase 2a, Randomized, Placebo-Controlled Human Challenge Trial to Evaluate the Efficacy and Safety of Molnupiravir in Healthy Participants Inoculated with Respiratory Syncytial VirusMickie H Cheng, Alex J Mann, Brian M Maas, et al.
Pulmonary Therapy|May 9, 2025
Correction: A Phase 2a, Randomized, Placebo-Controlled Human Challenge Trial to Evaluate the Efficacy and Safety of Molnupiravir in Healthy Participants Inoculated with Respiratory Syncytial VirusMickie H Cheng, Alex J Mann, Brian M Maas, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 17, 2023
Quantification of clesrovimab, an investigational, half-life extended, anti-respiratory syncytial virus protein F human monoclonal antibody in the nasal epithelial lining fluid of healthy adultsJia Yao Phuah, Brian M Maas, Aimin Tang, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Medical Informatics = Medecine Et Informatique|April 1, 1988
Information systems for the community health servicesD E Avison, C P Catchpole
Nursing Times|August 1, 1987
Computers in nursing news. The tale of two systemsP Catchpole, D Avison, S Peart
Health Services Management|September 6, 1990
Making sense of Chinese walls or how to sort the purchasers from the providersP Catchpole, S Phoenix, D Ellis, et al.
Royal Society of Health Journal|February 1, 1982
The Quebec Medicare ProgrammeM Shipley, M Agass, A Bell, et al.
The Journal of General Virology|February 27, 2003
Alternative base pairs attenuate influenza A virus when introduced into the duplex region of the conserved viral RNA promoter of either the NS or the PA geneA P Catchpole, L J Mingay, E Fodor, et al.
BMC Research Notes|August 31, 2018
The manufacturing of human viral challenge agents for use in clinical studies to accelerate the drug development processAndrew P Catchpole, Daniel J Fullen, Nicolas Noulin, et al.
Eclinicalmedicine|October 4, 2024
Changes in memory and cognition during the SARS-CoV-2 human challenge studyWilliam Trender, Peter J Hellyer, Ben Killingley, et al.
Pulmonary Therapy|April 2, 2025
A Phase 2a, Randomized, Placebo-Controlled Human Challenge Trial to Evaluate the Efficacy and Safety of Molnupiravir in Healthy Participants Inoculated with Respiratory Syncytial VirusMickie H Cheng, Alex J Mann, Brian M Maas, et al.
Pulmonary Therapy|May 9, 2025
Correction: A Phase 2a, Randomized, Placebo-Controlled Human Challenge Trial to Evaluate the Efficacy and Safety of Molnupiravir in Healthy Participants Inoculated with Respiratory Syncytial VirusMickie H Cheng, Alex J Mann, Brian M Maas, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 17, 2023
Quantification of clesrovimab, an investigational, half-life extended, anti-respiratory syncytial virus protein F human monoclonal antibody in the nasal epithelial lining fluid of healthy adultsJia Yao Phuah, Brian M Maas, Aimin Tang, et al.
Pageof 3